Preparing and Administering Kogenate FS with Vial Adapter
Kogenate FS is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Always follow the specific reconstitution and administration procedures provided by your physician. Take a look at our instructions for use for general information on preparing and administering Kogenate FS with Vial Adapter.
Understanding vial sizes and dosing Kogenate FS
Kogenate FS comes in a wide range of vial sizes because different types of bleeds and circumstances require different dosages.
Storing Kogenate FS – at room temperature
Kogenate FS can be stored at room temperature (up to 77°F) for up to 1 year – so it's ready for use when you need it.
Store Kogenate® FS at 36°F to 46°F for up to 30 months from the date of manufacture. Within this period, Kogenate® FS may be stored for a period of up to 12 months at temperatures up to 77°F. The starting date of room temperature storage should be clearly recorded on the unopened product carton. Once stored at room temperature, the product must not be returned to the refrigerator. The shelf-life then expires after the storage at room temperature (up to 12 months) or the expiration on the product vial, whichever is earlier.
BayCuff™ – self-infusion training made simple
Get comfortable self-infusing Kogenate FS with BayCuff™ – a self-infusion training system that allows you to practice the technique of self-infusion without actually infusing.
How do I get started?
When talking with your doctor about Kogenate FS, it helps to be prepared.
Kogenate® FS Antihemophilic Factor (Recombinant) is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A.
Kogenate FS is used to treat and control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Kogenate FS when you have surgery. Kogenate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). Kogenate FS can reduce the risk of joint damage in children without pre-existing joint damage when used regularly.
Kogenate FS is not used to treat von Willebrand disease.
Important Safety Information
You should not use Kogenate FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS.
Tell your healthcare provider if you have been told you have heart disease or are at risk for heart disease.
You could have an allergic reaction to Kogenate FS. Call your healthcare provider right away and stop treatment if you get rash or hives, itching, tightness of the chest or throat, difficulty breathing, light-headed, dizziness, nausea or a decrease in blood pressure.
Your body can make antibodies, called “inhibitors,” against Kogenate FS, which may stop Kogenate FS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to factor VIII.
Other common side effects of Kogenate FS are local injection site reactions (pain, swelling, irritation at infusion site) and infections from implanted injection device. Tell your healthcare provider about any side effect that bothers you or does not go away.
Call your healthcare provider right away if bleeding is not controlled after using Kogenate FS.
For important risk and use information, please see full prescribing information.